Ro-3306

Ro-3306 is an inhibitor of CDK1 and ERK and related targets used in studies of MAPK / ERK Signaling and Cell Cycle Regulation and related signaling programs. It is especially relevant when investigators need a named chemical input and interpretable readouts connected to mitogenic kinase cascades, proliferation control, and differentiation-linked signaling and checkpoint control, mitotic progression, and proliferation timing in apoptosis, cancer, and cell cycle models.

By inhibiting CDK1 and ERK and related targets, Ro-3306 can be used to examine mitogenic kinase cascades, proliferation control, and differentiation-linked signaling and checkpoint control, mitotic progression, and proliferation timing. The kinase annotation adds relevance to biochemical kinase assays, phospho-signaling studies, and selectivity profiling, together with downstream-response mapping in the same experimental setting. In apoptosis, cancer, and cell cycle models, these readouts can be combined with viability, reporter, localization, biochemical conversion, or morphology endpoints to refine experimental interpretation.

Research Applications

• Target-focused assays involving CDK1 and ERK and related targets
• Pathway perturbation studies connected to MAPK / ERK Signaling and Cell Cycle Regulation and related signaling programs
• Concentration-response inhibition and target-dependence studies
• Biochemical kinase assays, phospho-signaling studies, and selectivity profiling

Overall, Ro-3306 is appropriate when a defined chemical perturbant is needed to connect CDK1 and ERK and related targets with measurable biochemical, transcriptional, electrophysiological, imaging, or phenotypic readouts in apoptosis, cancer, and cell cycle models. This profile is suited to mechanistic follow-up, comparative profiling, and assay optimization under defined exposure conditions.